Literature DB >> 23222270

In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L.

Chong Zhang1, Shuang-shuang Zhou, Lin-yi Feng, Da-yong Zhang, Neng-ming Lin, Li-huang Zhang, Jian-ping Pan, Jun-bo Wang, Jie Li.   

Abstract

AIM: To examine the anti-cancer effects of chamaejasmenin B and neochamaejasmin C, two biflavonones isolated from the root of Stellera chamaejasme L (known as the traditional Chinese herb Rui Xiang Lang Du) in vitro.
METHODS: Human liver carcinoma cell lines (HepG2 and SMMC-7721), a human non-small cell lung cancer cell line (A549), human osteosarcoma cell lines (MG63, U2OS, and KHOS), a human colon cancer cell line (HCT-116) and a human cervical cancer cell line (HeLa) were used. The anti-proliferative effects of the compounds were measured using SRB cytotoxicity assay. DNA damage was detected by immunofluorescence and Western blotting. Apoptosis and cell cycle distribution were assessed using flow cytometry analysis. The expression of the related proteins was examined with Western blotting analysis.
RESULTS: Both chamaejasmenin B and neochamaejasmin C exerted potent anti-proliferative effects in the 8 human solid tumor cell lines. Chamaejasmenin B (the IC(50) values ranged from 1.08 to 10.8 μmol/L) was slightly more potent than neochamaejasmin C (the IC(50) values ranged from 3.07 to 15.97 μmol/L). In the most sensitive A549 and KHOS cells, the mechanisms underlying the anti-proliferative effects were characterized. The two compounds induced prominent expression of the DNA damage marker γ-H2AX as well as apoptosis. Furthermore, treatment of the cells with the two compounds caused prominent G(0)/G(1) phase arrest.
CONCLUSION: Chamaejasmenin B and neochamaejasmin C are potential anti-proliferative agents in 8 human solid tumor cell lines in vitro via inducing cell cycle arrest, apoptosis and DNA damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23222270      PMCID: PMC4011604          DOI: 10.1038/aps.2012.158

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  39 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  New biflavanones and bioactive compounds from Stellera chamaejasme L.

Authors:  Z H Xu; G W Qin; X Y Li; R S Xu
Journal:  Yao Xue Xue Bao       Date:  2001-09

Review 3.  Oxidative DNA damage: mechanisms, mutation, and disease.

Authors:  Marcus S Cooke; Mark D Evans; Miral Dizdaroglu; Joseph Lunec
Journal:  FASEB J       Date:  2003-07       Impact factor: 5.191

4.  DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells.

Authors:  Joana Dinis; Vânia Silva; Marta Gromicho; Célia Martins; António Laires; Purificação Tavares; Paula Rendeiro; Fátima Torres; José Rueff; António Rodrigues
Journal:  Leuk Lymphoma       Date:  2012-05-21

5.  Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.

Authors:  Wen-Wen Huang; Jai-Sing Yang; Shu-Jen Pai; Ping-Ping Wu; Shu-Jen Chang; Fu-Shin Chueh; Ming-Jen Fan; Shang-Ming Chiou; Hsiu-Maan Kuo; Chin-Chung Yeh; Po-Yuan Chen; Minoru Tsuzuki; Jing-Gung Chung
Journal:  Mutat Res       Date:  2012-01-20       Impact factor: 2.433

Review 6.  Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.

Authors:  T Owa; H Yoshino; K Yoshimatsu; T Nagasu
Journal:  Curr Med Chem       Date:  2001-10       Impact factor: 4.530

7.  Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

Authors:  A Suzuki; M Hayashida; T Ito; H Kawano; T Nakano; M Miura; K Akahane; K Shiraki
Journal:  Oncogene       Date:  2000-07-06       Impact factor: 9.867

8.  Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.

Authors:  Diana Zurlo; Cinzia Leone; Gemma Assante; Salvatore Salzano; Giovanni Renzone; Andrea Scaloni; Caterina Foresta; Vittorio Colantuoni; Angelo Lupo
Journal:  Mol Carcinog       Date:  2011-10-24       Impact factor: 4.784

9.  P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.

Authors:  Chong Zhang; Hong Zhu; Xiaochun Yang; Jianshu Lou; Difeng Zhu; Wei Lu; Qiaojun He; Bo Yang
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-02       Impact factor: 4.553

Review 10.  The ups and downs of tannins as inhibitors of poly(ADP-ribose)glycohydrolase.

Authors:  Christian Blenn; Philippe Wyrsch; Felix R Althaus
Journal:  Molecules       Date:  2011-02-22       Impact factor: 4.411

View more
  8 in total

Review 1.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

2.  ESC reverses epithelial mesenchymal transition induced by transforming growth factor-β via inhibition of Smad signal pathway in HepG2 liver cancer cells.

Authors:  Xiao-Ni Liu; Shuang Wang; Qing Yang; Ya-Jie Wang; De-Xi Chen; Xiao-Xin Zhu
Journal:  Cancer Cell Int       Date:  2015-12-10       Impact factor: 5.722

3.  Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.

Authors:  Yingpeng Li; Xiuyan Li; Qingxia Guan; Chunjing Zhang; Ting Xu; Yujing Dong; Xinyu Bai; Weiping Zhang
Journal:  Int J Nanomedicine       Date:  2017-02-22

4.  HOPX Is an Epigenetically Inactivated Tumor Suppressor and Overexpression of HOPX Induce Apoptosis and Cell Cycle Arrest in Breast Cancer.

Authors:  Qinghua You; Yuanyuan Geng; Huiying Ye; Guixiang Zhu; Xiaofang Gao; Hongbo Zhu
Journal:  Onco Targets Ther       Date:  2020-06-23       Impact factor: 4.147

5.  Inhibitory effects of neochamaejasmin B on P-glycoprotein in MDCK-hMDR1 cells and molecular docking of NCB binding in P-glycoprotein.

Authors:  Lanying Pan; Haihong Hu; Xiangjun Wang; Lushan Yu; Huidi Jiang; Jianzhong Chen; Yan Lou; Su Zeng
Journal:  Molecules       Date:  2015-02-11       Impact factor: 4.411

6.  Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.

Authors:  Ya Jie Wang; Qi Li; Hong Bin Xiao; Yu Jie Li; Qing Yang; Xiao Xi Kan; Ying Chen; Xiao Ni Liu; Xiao Gang Weng; Xi Chen; Wei Yan Cai; Yan Guo; He Fei Huang; Xiao Xin Zhu
Journal:  Drug Des Devel Ther       Date:  2015-09-22       Impact factor: 4.162

7.  Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells.

Authors:  Lingling Si; Xinyan Yan; Yan Wang; Boxue Ren; Huanhuan Ren; Yangfang Ding; Qiusheng Zheng; Defang Li; Ying Liu
Journal:  Front Oncol       Date:  2020-04-02       Impact factor: 6.244

8.  Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway.

Authors:  Yangfang Ding; Qi Xie; Wenjing Liu; Zhaohai Pan; Xinmei Fan; Xiaoyu Chen; Mingkai Li; Wei Zhao; Defang Li; Qiusheng Zheng
Journal:  Oxid Med Cell Longev       Date:  2020-01-20       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.